Basel, Switzerland

Segesser Bernhard

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Segesser Bernhard: Innovator in Pain and Inflammation Treatment

Introduction

Segesser Bernhard is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pain management and inflammation treatment. His innovative approach focuses on the use of proline, a naturally occurring amino acid, to address various inflammatory conditions.

Latest Patents

Segesser holds a patent for "Methods of treating pain and inflammation with proline." This patent describes methods for using proline specifically for the treatment of inflammatory conditions, rheumatic and non-rheumatic pain, as well as postoperative or posttraumatic pain. His work in this area has the potential to improve the quality of life for many individuals suffering from chronic pain.

Career Highlights

Throughout his career, Segesser has dedicated himself to researching and developing effective treatments for pain and inflammation. His innovative methods have garnered attention in the medical community, showcasing his commitment to advancing healthcare solutions.

Collaborations

Segesser has worked alongside Hans Meyer, contributing to the development of new treatment methodologies. Their collaboration has focused on enhancing the efficacy of pain management strategies.

Conclusion

Segesser Bernhard's contributions to the field of pain and inflammation treatment through his patent on proline demonstrate his innovative spirit and dedication to improving patient care. His work continues to inspire advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…